Open AccessBCR/ABL1 GENE EXPRESSION RATE AT 3 MONTHS OF THYROSINKINASE INHIBITORS THERAPY AS A PROGNOSTIC FACTOR OF THERAPY RESPONSE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
Author(s) -
I. V. Dmytrenko,
Ж. М. Мінченко,
Zoya Martina,
T Yu Shlyakhtychenko,
Oleksandr Dmytrenko,
Irina Dyagil
Publication year - 2019
Publication title -
vìsnik problem bìologìï ì medicini
Language(s) - English
Resource type - Journals
eISSN - 2523-4110
pISSN - 2077-4214
DOI - 10.29254/2077-4214-2019-3-152-223-226
Subject(s) - myeloid leukemia , oncology , medicine , breakpoint cluster region , chronic myeloid leukaemia , induction therapy , cancer research , genetic enhancement , gene , chemotherapy , biology , receptor , genetics